Ainos Inc.

0.53
-0.01 (-2.73%)
At close: Apr 04, 2025, 1:34 PM
-2.73%
Bid 0.51
Market Cap 8.16M
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) -1.56
PE Ratio (ttm) -0.34
Forward PE n/a
Analyst n/a
Ask 0.54
Volume 115,491
Avg. Volume (20D) 662,236
Open 0.51
Previous Close 0.54
Day's Range 0.50 - 0.54
52-Week Range 0.40 - 1.46
Beta 1.85

About AIMD

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-...

Industry Biotechnology
Sector Healthcare
IPO Date Jan 8, 2021
Employees 44
Stock Exchange NASDAQ
Ticker Symbol AIMD
Full Company Profile
7 months ago
+8.06%
Ainos shares are trading higher after the company ... Unlock content with Pro Subscription
7 months ago
+1.2%
Ainos shares are trading higher after the company announced that it has obtained exclusive licenses for a total of 10 invention patents and patent applications from Taiwan Carbon Nano Technology.